MYNXGRIP VASCULAR CLOSURE DEVICE 6F/7F
Report
- Report Number
- 3004939290-2013-00085
- Event Type
- Injury
- Date Received
- March 12, 2013
- Date of Event
- February 18, 2013
- Report Date
- February 18, 2013
- Manufacturer
- ACCESSCLOSURE, INC.
- Product Code
- MGB
- PMA / PMN Number
- P040044
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE WAS NOT RETURNED; THEREFORE, A PHYSICAL INVESTIGATION COULD NOT BE PERFORMED. BASED ON THE INFORMATION PROVIDED, THE ROOT CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED. THE REVIEW OF THE LHR (LOT F1302201) INDICATED THAT THE DEVICE LOT MET ALL ESTABLISHED PERFORMANCE CRITERIA PRIOR TO SHIPMENT.
IT WAS REPORTED BY THE ACI SALES PROFESSIONAL THAT A (B)(6) FEMALE PATIENT UNDERWENT AN INTERVENTIONAL CORONARY PROCEDURE ON (B)(6) 2013. ACCESS WAS OBTAINED AT PROFUNDA VIA A 6F SHEATH (MODEL UNKNOWN). PERI-PROCEDURE, THE PATIENT WAS ANTICOAGULATED WITH HEPARIN. A PRE-PROCEDURE FEMORAL ANGIOGRAM SHOWED NO PRESENCE OF PVD/CALCIUM AT THE ACCESS SITE AND THE VESSEL SIZE APPROXIMATELY 7MM. FOLLOWING THE PROCEDURE, THE PHYSICIAN SELECTED THE MYNXGRIP VASCULAR CLOSURE DEVICE 6F/7F TO CLOSE THE ACCESS SITE. IT WAS REPORTED THAT FOLLOWING THE POST DEPLOYMENT HOLD OF 5 MINUTES, A 3CM X 3CM HEMATOMA DEVELOPED AT THE ACCESS SITE. MANUAL COMPRESSION WAS APPLIED AT THE ACCESS SITE FOR 5 MINUTES AT WHICH TIME THE HEMATOMA SEEMED TO SOFTEN AND RESOLVE ITSELF. A SANDBAG WAS PLACED ON THE GROIN AS AN ADDED PRECAUTION. WHEN THE PATIENT REACHED THE RECOVERY ROOM, THE HEMATOMA HAD RE-DEVELOPED THIS TIME THE SIZE OF THE HEMATOMA WAS APPROXIMATELY 4CM X 4CM. AN ADDITIONAL 10 MINUTES OF MANUAL COMPRESSION WERE APPLIED AT THE ACCESS SITE, FOLLOWED BY PLACEMENT OF A FEMOSTOP DEVICE. THE PATIENT WAS HOSPITALIZED FOR UNRELATED AND UNSPECIFIED REASONS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 102980 | MYNXGRIP VASCULAR CLOSURE DEVICE 6F/7F | MGB | MGB | ACCESSCLOSURE, INC. | MX6721 | F1302201 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | Required Intervention | HEPARIN |